Gw Pharma ADR (GWPH) Stock Price & Overview

NASDAQ:GWPH

Current stock price

218.96
-0.32 (-0.15%)
At close:
219.58
+0.62 (+0.28%)
After Hours:

The current stock price of GWPH is 218.96 null. Today GWPH is down by -0.15%. In the past month the price increased by 0.6%. In the past year, price increased by 101.96%.

GWPH Key Statistics

52-Week Range87.0655 - 219.57
Current GWPH stock price positioned within its 52-week range.
1-Month Range217.18 - 219.57
Current GWPH stock price positioned within its 1-month range.
Market Cap
6.864B
P/E
N/A
Fwd P/E
326.81
EPS (TTM)
-1.86
Dividend Yield
N/A

GWPH Stock Performance

Today
-0.15%
1 Week
+0.10%
1 Month
+0.60%
3 Months
+2.05%
Longer-term
6 Months +91.00%
1 Year +101.96%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

GWPH Stock Chart

Gw Pharma ADR / GWPH Daily stock chart

GWPH Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to GWPH. When comparing the yearly performance of all stocks, GWPH is one of the better performing stocks in the market, outperforming 76.48% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

GWPH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GWPH. GWPH has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GWPH Earnings

Next Earnings DateFeb 18, 2022
Last Earnings DateN/A

GWPH Forecast & Estimates


Analysts
Analysts64.4
Price TargetN/A
EPS Next Y136.02%
Revenue Next YearN/A

GWPH Financial Highlights

Over the last trailing twelve months GWPH reported a non-GAAP Earnings per Share(EPS) of -1.86. The EPS decreased by -675% compared to the year before.


Income Statements
Revenue(TTM)559.04M
Net Income(TTM)-69.84M
Industry RankSector Rank
PM (TTM) -12.49%
ROA -7.47%
ROE N/A
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-10.71%
Sales Q2Q%26.39%
EPS 1Y (TTM)-675%
Revenue 1Y (TTM)42.35%

GWPH Ownership

Ownership
Inst Owners0%
Shares31.35M
Float28.31M
Ins Owners0.37%
Short Float %N/A
Short RatioN/A

About GWPH

Company Profile

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.

Company Info

Gw Pharma ADR

SOVEREIGN HOUSE VISION PARK HISTON

CAMBRIDGE X0 CB24 9BZ

CEO: Justin Gover

Phone: 44-12-2326-6800

Gw Pharma ADR / GWPH FAQ

Can you describe the business of Gw Pharma ADR?

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.


What is the current price of GWPH stock?

The current stock price of GWPH is 218.96 null. The price decreased by -0.15% in the last trading session.


Does GWPH stock pay dividends?

GWPH does not pay a dividend.


What is the ChartMill technical and fundamental rating of GWPH stock?

GWPH has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is Gw Pharma ADR (GWPH) stock traded?

GWPH stock is listed on the Nasdaq exchange.